Business Description
Talphera Inc
NAICS : 325411
SIC : 2833
ISIN : US00444T1007
Total Employee Number:
12Description
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.61 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -19.36 | |||||
Beneish M-Score | -8.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 55.2 | |||||
3-Year FCF Growth Rate | 58.9 | |||||
3-Year Book Growth Rate | -49.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.72 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.16 | |||||
9-Day RSI | 54.43 | |||||
14-Day RSI | 57.94 | |||||
3-1 Month Momentum % | 33.09 | |||||
6-1 Month Momentum % | 13.69 | |||||
12-1 Month Momentum % | 144.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.3 | |||||
Quick Ratio | 5.3 | |||||
Cash Ratio | 5.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -81.5 | |||||
Shareholder Yield % | -5.89 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1451600 | |||||
Net Margin % | -1425300 | |||||
EBITDA Margin % | -1564500 | |||||
FCF Margin % | -971600 | |||||
OCF Margin % | -971600 | |||||
ROE % | -106.5 | |||||
ROA % | -58.35 | |||||
ROIC % | -148.92 | |||||
3-Year ROIIC % | -28.87 | |||||
ROCE % | -73.48 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1320 | |||||
PB Ratio | 3.58 | |||||
Price-to-Tangible-Book | 7.13 | |||||
EV-to-EBIT | -3.03 | |||||
EV-to-EBITDA | -3.03 | |||||
EV-to-Revenue | 47400 | |||||
EV-to-Forward-Revenue | 137.55 | |||||
EV-to-FCF | -4.2 | |||||
| Price-to-Net-Current-Asset-Value | 7.13 | |||||
| Price-to-Net-Cash | 7.13 | |||||
Earnings Yield (Greenblatt) % | -33 | |||||
FCF Yield % | -16.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Talphera Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.001 | ||
| EPS (TTM) (€) | -0.267 | ||
| Beta | 1.1359 | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 0.53 | ||
| Volatility % | 97.41 | ||
| 14-Day RSI | 57.94 | ||
| 14-Day ATR (€) | 0.069778 | ||
| 20-Day SMA (€) | 1.124 | ||
| 12-1 Month Momentum % | 144.26 | ||
| 52-Week Range (€) | 0.325 - 1.27 | ||
| Shares Outstanding (Mil) | 51.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Talphera Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Talphera Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 16:30 | In 105 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 104 days | ||
| General meeting for 2026 | 2026-10-23 10:00 | In 85 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 16:30 | In 15 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 14 days | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 0.72 (-0.69%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.72 (-0.69%) | ||
| Virtual Investor & Analyst Event | 2026-03-23 11:00 | 0.72 (+5.45%) | ||
| Annual report for 2025 | 2026-03-23 | 0.72 (+5.45%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-23 | 0.72 (+5.45%) |
Show
Entries
Talphera Inc Frequently Asked Questions
What is Talphera Inc(STU:R5XA)'s stock price today?
The current price of STU:R5XA is €1.14. The 52 week high of STU:R5XA is €1.27 and 52 week low is €0.33.
When is next earnings date of Talphera Inc(STU:R5XA)?
The next earnings date of Talphera Inc(STU:R5XA) is 2026-08-14 Est..
Does Talphera Inc(STU:R5XA) pay dividends? If so, how much?
Talphera Inc(STU:R5XA) does not pay dividend.
Press Release
Articles on Talphera Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers